Published in Infect Immun on November 01, 1995
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun (2008) 3.51
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun (2009) 2.22
Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. Infect Immun (2006) 1.87
High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect Immun (2000) 1.73
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect Immun (2000) 1.66
Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun (2000) 1.64
Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun (2004) 1.60
Genetic diversity and antigenic polymorphism in Plasmodium falciparum: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2. Infect Immun (2003) 1.44
Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun (2001) 1.44
Antigenic diversity and immune evasion by malaria parasites. Clin Diagn Lab Immunol (2004) 1.39
Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass. Infect Immun (1997) 1.38
Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection. BMC Infect Dis (2007) 1.37
Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol (2007) 1.37
A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1. Infect Immun (2006) 1.27
Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody response. Malar J (2009) 1.25
Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum. Infect Immun (1999) 1.19
Strain-specific humoral response to a polymorphic malaria vaccine. Infect Immun (2004) 1.18
Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon. Malar J (2003) 1.15
Antibody responses to infections with strains of Plasmodium falciparum expressing diverse forms of merozoite surface protein 2. Infect Immun (2001) 1.15
Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infect Immun (1997) 1.15
Plasmodium falciparum merozoite surface protein 6 displays multiple targets for naturally occurring antibodies that mediate monocyte-dependent parasite killing. Infect Immun (2005) 1.14
Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam. Infect Immun (2001) 1.11
New antigens for a multicomponent blood-stage malaria vaccine. Sci Transl Med (2014) 1.11
Temporal variation of the merozoite surface protein-2 gene of Plasmodium falciparum. Infect Immun (1998) 1.10
A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720. PLoS One (2011) 1.07
Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Infect Immun (2014) 1.06
Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front Immunol (2014) 1.06
Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection. Clin Exp Immunol (1997) 1.06
Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model. Infect Immun (2002) 1.05
Population dynamics of genetically diverse Plasmodium falciparum lineages: community-based prospective study in rural Amazonia. Parasitology (2009) 1.04
Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection. Parasite Immunol (2010) 1.01
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. Vaccine (2013) 1.00
Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria. Clin Infect Dis (2013) 0.99
Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians. Clin Vaccine Immunol (2007) 0.97
FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan. Malar J (2009) 0.97
Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort. Parasite Immunol (2010) 0.97
Genetic diversity in merozoite surface protein (MSP)-1 and MSP-2 genes of Plasmodium falciparum in a major endemic region of Iran. Korean J Parasitol (2007) 0.95
Dramatic declines in seropositivity as determined with crude extracts of Plasmodium falciparum schizonts between 2000 and 2010 in Dielmo and Ndiop, Senegal. Malar J (2014) 0.95
Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens. PLoS One (2009) 0.94
Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies. Infect Immun (2010) 0.93
Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum. Clin Med Res (2006) 0.92
Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals. Malar J (2007) 0.91
Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins. Infect Immun (2005) 0.91
Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2. Infect Immun (2012) 0.90
Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites. PLoS Pathog (2015) 0.90
Plasmodium falciparum- and merozoite surface protein 1-specific antibody isotype balance in immune Senegalese adults. Infect Immun (1997) 0.90
Identification of a vaccine candidate antigen, PfMAg-1, from Plasmodium falciparum with monoclonal antibody M26-32. Parasitol Res (2009) 0.89
Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity. Sci Rep (2016) 0.87
Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia. Clin Vaccine Immunol (2006) 0.86
Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children. Infect Immun (2016) 0.83
Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study. Malar J (2011) 0.81
Differential recognition of Plasmodium falciparum merozoite surface protein 2 variants by antibodies from malaria patients in Brazil. Clin Diagn Lab Immunol (2003) 0.81
Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity. Vaccine (2015) 0.80
Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2. Sci Rep (2016) 0.80
Conformational dynamics and antigenicity in the disordered malaria antigen merozoite surface protein 2. PLoS One (2015) 0.79
Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity. BMC Med (2015) 0.79
Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate. Sci Rep (2015) 0.78
Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains. Malar J (2014) 0.78
Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life. Int J Parasitol (2016) 0.75
Antigenicity and immunogenicity of PvRALP1, a novel Plasmodium vivax rhoptry neck protein. Malar J (2015) 0.75
Genetic diversity and antibody responses against Plasmodium falciparum vaccine candidate genes from Chhattisgarh, Central India: Implication for vaccine development. PLoS One (2017) 0.75
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg (1987) 6.58
Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol (1974) 5.22
Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett (1985) 4.23
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun (1992) 3.42
Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol (1990) 3.20
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Monoclonal antibodies (McAbs) to determinants on human gamma chains: properties of antibodies showing subclass restriction or subclass specificity. Immunology (1982) 2.79
Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med (1994) 2.50
Identification of two integral membrane proteins of Plasmodium falciparum. Proc Natl Acad Sci U S A (1988) 2.35
Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum. Mol Biochem Parasitol (1990) 2.16
Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res Immunol (1991) 2.06
Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol Cell Biol (1991) 1.68
Aspects of the molecular structure of IgG subclasses. Monogr Allergy (1986) 1.56
Structural diversity in the Plasmodium falciparum merozoite surface antigen 2. Proc Natl Acad Sci U S A (1991) 1.55
Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J Infect Dis (1990) 1.49
Population genetics of Plasmodium falciparum within a malaria hyperendemic area. Parasitology (1991) 1.44
An epitope recognised by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparum. Mol Biochem Parasitol (1988) 1.40
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg (1994) 1.30
Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population. Infect Immun (1992) 1.29
Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the 2nd IUIS/WHO collaborative study. Immunol Lett (1992) 1.26
Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2. Mol Biochem Parasitol (1990) 1.26
Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2. J Immunol (1992) 1.22
Major surface antigen p190 of Plasmodium falciparum: detection of common epitopes present in a variety of plasmodia isolates. EMBO J (1988) 1.17
Plasmodium falciparum genetic diversity can be characterised using the polymorphic merozoite surface antigen 2 (MSA-2) gene as a single locus marker. Mol Biochem Parasitol (1994) 1.16
46-53 kilodalton glycoprotein from the surface of Plasmodium falciparum merozoites. Mol Biochem Parasitol (1989) 1.15
What is the function of MSP-I on the malaria merozoite? Parasitol Today (1994) 1.08
Analysis of human T cell response to two Plasmodium falciparum merozoite surface antigens. Eur J Immunol (1989) 1.00
Allelic variants of the Plasmodium falciparum merozoite surface antigen 2 (MSA-2) in a geographically restricted area of Irian Jaya. Mol Biochem Parasitol (1994) 0.99
ELISAs for parasitologists: or lies, damned lies and ELISAs. Parasitol Today (1993) 0.96
Methods of detecting IgG subclass proteins and antibodies. Monogr Allergy (1986) 0.87
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39
Nonmuscle actin-binding proteins. Annu Rev Cell Biol (1985) 5.46
A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med (1990) 4.90
National field evaluation of a defined substrate method for the simultaneous enumeration of total coliforms and Escherichia coli from drinking water: comparison with the standard multiple tube fermentation method. Appl Environ Microbiol (1988) 3.83
Genome size and the proportion of repeated nucleotide sequence DNA in plants. Biochem Genet (1974) 3.66
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA (1999) 3.11
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06
A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol (1998) 2.94
Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J Exp Med (1997) 2.92
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer (1992) 2.91
National field evaluation of a defined substrate method for the simultaneous detection of total coliforms and Escherichia coli from drinking water: comparison with presence-absence techniques. Appl Environ Microbiol (1989) 2.88
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med (1985) 2.73
Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis (2002) 2.61
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc Natl Acad Sci U S A (1988) 2.60
Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol Biochem Parasitol (1987) 2.56
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Full-scale studies of factors related to coliform regrowth in drinking water. Appl Environ Microbiol (1996) 2.47
Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet (1996) 2.46
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol (1999) 2.39
Mr 26,000 antigen of Schistosoma japonicum recognized by resistant WEHI 129/J mice is a parasite glutathione S-transferase. Proc Natl Acad Sci U S A (1986) 2.35
Enumeration of total coliforms and Escherichia coli from source water by the defined substrate technology. Appl Environ Microbiol (1990) 2.30
Structural constraints on RNA virus evolution. J Virol (1999) 2.24
Maintaining the immunological balance in parasitic infections: a role for TGF-beta? Parasitol Today (2000) 2.19
The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol (2003) 2.18
Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum. J Exp Med (1985) 2.15
Colorimetric detection of specific DNA segments amplified by polymerase chain reactions. Proc Natl Acad Sci U S A (1989) 2.14
Antigenic diversity in the human malaria parasite Plasmodium falciparum. Science (1982) 2.09
A small angle light scattering device for planar connective tissue microstructural analysis. Ann Biomed Eng (1997) 2.02
Why the success of dentistry's charitable foundation should matter to you. J Can Dent Assoc (2001) 2.02
Extreme heterogeneity of Ty1-copia group retrotransposons in plants. Mol Gen Genet (1992) 1.81
Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up. Neurology (1987) 1.81
Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol Cell Biol (1991) 1.68
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect Immun (2000) 1.66
Heterosexual transmission of hepatitis C virus. Lancet (1993) 1.65
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study. Br J Cancer (2003) 1.62
Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J Exp Med (1998) 1.57
The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients. Parasitology (1991) 1.55
Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol (1996) 1.46
In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther (1996) 1.45
Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun (2001) 1.44
Population genetics of Plasmodium falciparum within a malaria hyperendemic area. Parasitology (1991) 1.44
Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol (1998) 1.41
Evidence for the possible existence of a superheavy element with atomic number 112. Nature (1971) 1.40
Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc Natl Acad Sci U S A (1990) 1.40
Toward a definition of health services management: a humanist orientation. Int J Health Serv (1974) 1.39
Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumours. Ann Oncol (1992) 1.38
Simplified colorimetric analysis of polymerase chain reactions: detection of HIV sequences in AIDS patients. Gene (1990) 1.34
Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun (1993) 1.31
Is everyone in agreement? An exploration of within-group agreement in employee perceptions of the work environment. J Appl Psychol (2001) 1.30
Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest (1986) 1.30
Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population. Infect Immun (1992) 1.29
Non-secretory multiple myeloma: a report of 13 cases with a review of the literature. Hematol Oncol (1987) 1.29
The aortic valve microstructure: effects of transvalvular pressure. J Biomed Mater Res (1998) 1.29
Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection. Infect Immun (1996) 1.29
Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. Trans R Soc Trop Med Hyg (1993) 1.28
Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Mol Biochem Parasitol (1997) 1.28
Device choice and experience level in endoscopic foreign object retrieval: an in vivo study. Gastrointest Endosc (1997) 1.25
Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. J Infect Dis (2001) 1.24
Defined substrate technology method for rapid and specific simultaneous enumeration of total coliforms and Escherichia coli from water: collaborative study. J Assoc Off Anal Chem (1991) 1.24
Inhibitory monoclonal antibodies recognise epitopes adjacent to a proteolytic cleavage site on the RAP-1 protein of Plasmodium falciparum. Mol Biochem Parasitol (1992) 1.23
The statistical analysis of data from immunoepidemiological studies. J Immunol Methods (1992) 1.22
The quantitative separation of 3',5'-cyclic adenosine monophosphate, adenosine-5'-monophosphate, adenosine-5'-diphosphate, and adenosine-5'-triphosphate by ion-exchange chromatography on diethylaminoethyl sephadex. J Chromatogr (1970) 1.22
Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages. J Exp Med (1988) 1.21
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21
Identification of GB virus C variants by phylogenetic analysis of 5'-untranslated and coding region sequences. J Virol (1997) 1.19
Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay. Parasite Immunol (1987) 1.19
Endoscopic ultrasound-guided real-time fine-needle aspiration: clinicopathologic features of 60 patients. Diagn Cytopathol (1998) 1.18
Regulated production of an influenza virus spliced mRNA mediated by virus-specific products. EMBO J (1985) 1.18
Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clin Exp Immunol (1992) 1.17
Generating fusions to glutathione S-transferase for protein studies. Methods Enzymol (2000) 1.16
Immunosuppression in murine malaria. I. Response to type III pneumococcal polysaccharide. Immunology (1977) 1.16
46-53 kilodalton glycoprotein from the surface of Plasmodium falciparum merozoites. Mol Biochem Parasitol (1989) 1.15
Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. Am Rev Respir Dis (1988) 1.15
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans R Soc Trop Med Hyg (1992) 1.15
Quantitative measurement of plasma gelsolin and its incorporation into fibrin clots. J Lab Clin Med (1987) 1.14
Human odorant evoked responses: effects of trigeminal or olfactory deficit. Electroencephalogr Clin Neurophysiol (1971) 1.12
The role of homoeologous group 1 chromosomes in the control of rRNA genes in wheat. Biochem Genet (1974) 1.12
Endoscopic ultrasound-guided real-time fine-needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions. J Clin Oncol (1997) 1.11
Restricted genetic and antigenic diversity of Plasmodium falciparum under mesoendemic transmission in the Venezuelan Amazon. Parasitology (2002) 1.11
Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease. Ann Neurol (2000) 1.10
The development and evaluation of a mu-capture ELISA detecting Chlamydia-specific IgM. Epidemiol Infect (1988) 1.10
Dynamic in vitro quantification of bioprosthetic heart valve leaflet motion using structured light projection. Ann Biomed Eng (2001) 1.09
Folate metabolism and the anticonvulsant efficacy of phenobarbital. Arch Neurol (1973) 1.08
Issues of aging and adherence to health interventions. Control Clin Trials (2000) 1.08
HLA-DR and -DQ gene polymorphism in West Africans is twice as extensive as in north European Caucasians: evolutionary implications. Proc Natl Acad Sci U S A (1991) 1.07
A Ty1-copia group retrotransposon sequence in a vertebrate. Mol Gen Genet (1992) 1.07
Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol (2000) 1.06
Detection in chimpanzees of a novel flavivirus related to GB virus-C/hepatitis G virus. J Gen Virol (1998) 1.06
Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination. Curr Top Microbiol Immunol (2005) 1.05
Accuracy of piezoelectric accelerometers measuring displacement of a spinal adjusting instrument. J Manipulative Physiol Ther (1986) 1.05
Differential antibody recognition of FC27-like Plasmodium falciparum merozoite surface protein MSP2 antigens which lack 12 amino acid repeats. Parasite Immunol (1996) 1.05